rs782115290

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_031407.7(HUWE1):​c.1188C>T​(p.Tyr396Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000276 in 1,161,442 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000037 ( 0 hom., 1 hem., cov: 21)
Exomes 𝑓: 0.000027 ( 0 hom. 15 hem. )

Consequence

HUWE1
NM_031407.7 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -0.115

Publications

0 publications found
Variant links:
Genes affected
HUWE1 (HGNC:30892): (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) This gene encodes a protein containing a C-terminal HECT (E6AP type E3 ubiquitin protein ligase) domain that functions as an E3 ubiquitin ligase. The encoded protein is required for the ubiquitination and subsequent degradation of the anti-apoptotic protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-related)). This protein also ubiquitinates the p53 tumor suppressor, core histones, and DNA polymerase beta. Mutations in this gene are associated with Turner type X-linked syndromic cognitive disability. [provided by RefSeq, Aug 2013]
HUWE1 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked syndromic, Turner type
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics, G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant X-53628547-G-A is Benign according to our data. Variant chrX-53628547-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211160.
BP7
Synonymous conserved (PhyloP=-0.115 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000266 (28/1052449) while in subpopulation MID AF = 0.000737 (3/4070). AF 95% confidence interval is 0.000201. There are 0 homozygotes in GnomAdExome4. There are 15 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 28 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HUWE1NM_031407.7 linkc.1188C>T p.Tyr396Tyr synonymous_variant Exon 15 of 84 ENST00000262854.11 NP_113584.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HUWE1ENST00000262854.11 linkc.1188C>T p.Tyr396Tyr synonymous_variant Exon 15 of 84 1 NM_031407.7 ENSP00000262854.6

Frequencies

GnomAD3 genomes
AF:
0.0000275
AC:
3
AN:
108956
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000284
Gnomad SAS
AF:
0.000406
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000190
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000865
AC:
1
AN:
115598
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000266
AC:
28
AN:
1052449
Hom.:
0
Cov.:
32
AF XY:
0.0000437
AC XY:
15
AN XY:
343215
show subpopulations
African (AFR)
AF:
0.000241
AC:
6
AN:
24878
American (AMR)
AF:
0.00
AC:
0
AN:
27893
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18619
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27123
South Asian (SAS)
AF:
0.0000402
AC:
2
AN:
49788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37661
Middle Eastern (MID)
AF:
0.000737
AC:
3
AN:
4070
European-Non Finnish (NFE)
AF:
0.0000159
AC:
13
AN:
818095
Other (OTH)
AF:
0.0000902
AC:
4
AN:
44322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000367
AC:
4
AN:
108993
Hom.:
0
Cov.:
21
AF XY:
0.0000318
AC XY:
1
AN XY:
31437
show subpopulations
African (AFR)
AF:
0.0000335
AC:
1
AN:
29871
American (AMR)
AF:
0.00
AC:
0
AN:
10142
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2616
East Asian (EAS)
AF:
0.000285
AC:
1
AN:
3507
South Asian (SAS)
AF:
0.000408
AC:
1
AN:
2453
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5544
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
210
European-Non Finnish (NFE)
AF:
0.0000190
AC:
1
AN:
52495
Other (OTH)
AF:
0.00
AC:
0
AN:
1477
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HUWE1: BP4, BP7, BS2 -

not specified Uncertain:1
Jan 30, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 03, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
0.38
DANN
Benign
0.52
PhyloP100
-0.12
PromoterAI
-0.023
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.7
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782115290; hg19: chrX-53655498; API